Ningxia Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Yinchuan China (1958)

Organization Overview

First Clinical Trial
2006
NCT00968929
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Nephrology, General Hospital of Ningxia Medical University, Ningxia | General Hospital of Ningxia Medical University | Gongli Hospital of Shanghai Pudong District | Hospital of Ningxia Medical University | Ningxia Medical University | People's Hospital of Ningxia | Pudong Gongli hospital of Shanghai | Pudong Gongli hospital, Shanghai | Pudong New Area People's Hospital | Shanghai Pudong Emergency Center | Shanghai Pudong Hospital | Shanghai Pudong New Area Gongli Hospital | Shanghai Pudong New Area People's Hospital | The Fourth People's Hospital of Ningxia Autonomous Region | The People's Hospital of Ningxia | Women and Children's Health Hospital of yinchuan City

Active Ingredients

Drugs in Phase 4 Trials (24)

aminolevulinic acid (levulan) (1 trial)

anlotinib (1 trial)

artesunate (1 trial)

carvedilol (coreg) (1 trial)

deng zhan sheng mai (1 trial)

entecavir (baraclude) (3 trials)

ethambutol (myambutol) (1 trial)

exenatide (byetta) (1 trial)

fuzhenghuayu (2 trials)

insulin human (humulin) (1 trial)

isoniazid (nydrazid) (1 trial)

levofloxacin (levaquin) (1 trial)

nadroparin (1 trial)

propofol (diprivan) (2 trials)

pyrazinamide (Aldinamide) (1 trial)

resminostat (1 trial)

rifampin (1 trial)

rituximab (rituxan) (1 trial)

sevoflurane (ultane) (2 trials)

sitagliptin (januvia) (1 trial)

somatropin (protropin) (1 trial)

streptokinase (streptase) (1 trial)

urokinase (kinlytic) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Phase 3 Trials (9)

docetaxel (taxotere) (2 trials)

irbesartan (avapro) (1 trial)

methylprednisolone (medrol) (2 trials)

minocycline (minocin) (1 trial)

mycophenolate (CellCept) (1 trial)

nedaplatin (1 trial)

prednisone (meticorten) (1 trial)

sodium chloride (10 trials)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 2 Trials (8)

aripiprazole (abilify) (1 trial)

fluvoxamine (luvox) (1 trial)

memantine (namenda) (1 trial)

Nelonemdaz (1 trial)

pirarubicin (1 trial)

sertraline (zoloft) (1 trial)

sintilimab (1 trial)

venlafaxine (effexor) (1 trial)

Drugs in Phase 1 Trials (7)

autologous car-t (1 trial)

autologous endothelial progenitor cells (1 trial)

chimeric exosomal tumor vaccines (1 trial)

cyclophosphamide (cytoxan) (3 trials)

fludarabine (fludara) (2 trials)

mesothelin car t cells (1 trial)

pemetrexed (alimta) (1 trial)

Drugs in Other Trials (21)

autologous hematopoietic stem cells (1 trial)

autologous immune cells (1 trial)

bupivacaine (Exparel) (1 trial)

dexamethasone (2 trials)

dexmedetomidine (precedex) (6 trials)

dezocine (dalgan) (1 trial)

doxapram (dopram) (1 trial)

doxorubicin (Doxil) (1 trial)

epirubicin (ellence) (1 trial)

etomidate (amidate) (1 trial)

fentanyl (Innovar) (1 trial)

hydroxyethyl starch (voluven) (2 trials)

lidocaine (xylocaine) (3 trials)

norepinephrine (levophed) (9 trials)

oxycodone (oxycontin) (1 trial)

pertuzumab (perjeta) (1 trial)

phenylephrine (Prefrin) (6 trials)

ringer's lactate (2 trials)

ropivacaine (naropin) (1 trial)

trastuzumab (herceptin) (1 trial)

walnut (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 4)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cerebral Infarction (Phase 2)

Cognitive Dysfunction (Phase 4)

Compulsive Personality Disorder (Phase 2)

Delirium (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Dwarfism, Pituitary (Phase 4)

Embolism (Phase 4)

Endocrine System Diseases (Phase 4)

Esophageal Squamous Cell Carcinoma (Phase 2)

Fibrosis (Phase 4)

Glomerulonephritis, IGA (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypertriglyceridemia (Phase 4)

Infarction (Phase 2)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 4)

Kidney Neoplasms (Phase 3)

Liver Cirrhosis (Phase 4)

Lupus Nephritis (Phase 4)

Nephritis (Phase 4)

Obsessive-Compulsive Disorder (Phase 2)

Pancreatitis (Phase 4)

Postoperative Complications (Phase 4)

Pulmonary Embolism (Phase 4)

Recurrence (Phase 2)

Stroke (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Uterine Cervical Neoplasms (Phase 3)

Venous Thrombosis (Phase 4)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial APIs: 69